Skip to content

DRUGS MADE IN AMERICA ACQ II CORP

US · DMII #3572 by market cap
10.23 -0.02 -0.20%
Periodic snapshot; not a real-time feed. · 2026-11-20 16:04

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 1 in the most recent period (2026/Q3).
  • Total institutional ownership fell 0.8 percentage points.

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
76.16% -0.77pp
Institutions
74 -1
As of
2026/Q3 vs. prior period

Holder types

Hedge Fund51.67%
Mutual Fund16.04%
Individual/Insider10.57%
Private Company5.62%
Government Pension Fund1.57%
VC/PE Fund0.82%
Public Company0.45%
Other13.27%

Top holders as of 2026-04-15

Drugs Made In America Acquisition II LLC 4.64% · 2.96M sh
Karpus Management Inc. 4.38% · 2.79M sh
Magnetar Capital Partners, LP 4.24% · 2.70M sh
MM Asset Management Inc 4.24% · 2.70M sh
Glazer Capital, LLC 3.68% · 2.34M sh
Highbridge Capital Management, LLC 3.52% · 2.24M sh
Charles Conaway 3.14% · 2.00M sh
Millennium Management LLC 3.13% · 1.99M sh
Hudson Bay Capital Management LP 3.09% · 1.97M sh
Wolverine Asset Management, LLC 2.89% · 1.84M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

10 filings tracked · 6 buys · 2 sells

NameRoleStake
Glenn Worman Former Chief Financial Officer 0.16%
Sridhar Prasad Independent Director 0.16%
Catherine Do Independent Director 0.16%
Myron Shulgan Independent Director 0.16%
Drugs Made In America Acquisition II LLC -- --

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2025-09-25 Glenn Worman Former Chief Financial Officer Other Acquisition +100,000 --
2025-09-25 Sridhar Prasad Independent Director Other Acquisition +100,000 --
2025-09-25 Catherine Do Independent Director Other Acquisition +100,000 --
2025-09-25 Myron Shulgan Independent Director Other Acquisition +100,000 --
2025-09-25 Drugs Made In America Acquisition II LLC -- Other Disposition -400,000 --
2025-09-25 Drugs Made In America Acquisition II LLC -- Private Acquisition +700,000 --
2025-09-25 Drugs Made In America Acquisition II LLC -- Private Disposition -7,966,667 --
2025-09-25 Drugs Made In America Acquisition II LLC -- Open Market Derivative Acquisiti +700,000 --
2025-09-23 Drugs Made In America Acquisition II LLC -- Initial Statement of Beneficial 0 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 16:04:04 · For reference only, not investment advice and not tailored to your situation.

DRUGS MADE IN AMERICA ACQ II CORP discussion 0 comments

Add a comment